Brasília – Pharmaceutical companies in Brazil are facing long delays at the National Institute of Industrial Property (INPI), with some patent applications taking around six years to be examined, according to an audit highlighted in a recent UOL Economia column. The prolonged timelines affect innovators across the sector and have drawn attention to structural challenges…